Recce Pharmaceuticals Ltd.ASX: RCE

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · · 9 pages · English

Summary by 6ix AI

Recce Pharmaceuticals Ltd. has released its quarterly cash flow statement and operational highlights for the first quarter of the fiscal year. Additionally, the company received a substantial R&D tax incentive rebate, enhancing its financial position as it progresses with clinical trials. The filing also notes the completion of a share purchase plan, raising funds to support ongoing research and development activities.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases